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Abstract
Background: We previously identified by genetic mapping an Anopheles gambiae chromosome region with strong
influence over the outcome of malaria parasite infection in nature. Candidate gene studies in the genetic interval, including
functional tests using the rodent malaria parasite Plasmodium berghei, identified a novel leucine-rich repeat gene, APL1, with
functional activity against P. berghei.
Principal Findings: Manual reannotation now reveals APL1 to be a family of at least 3 independently transcribed genes,
APL1A, APL1B, and APL1C. Functional dissection indicates that among the three known APL1 family members, APL1C alone is
responsible for host defense against P. berghei. APL1C functions within the Rel1-Cactus immune signaling pathway, which
regulates APL1C transcript and protein abundance. Gene silencing of APL1C completely abolishes Rel1-mediated host
protection against P. berghei, and thus the presence of APL1C is required for this protection. Further highlighting the
influence of this chromosome region, allelic haplotypes at the APL1 locus are genetically associated with and have high
explanatory power for the success or failure of P. berghei parasite infection.
Conclusions: APL1C functions as a required transducer of Rel1-dependent immune signal(s) to efficiently protect
mosquitoes from P. berghei infection, and allelic genetic haplotypes of the APL1 locus display distinct levels of susceptibility
and resistance to P. berghei.
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Introduction
Malaria is a global health problem resulting in over 1 million
deaths annually, with disproportionate mortality in African
children under the age of five [1]. Malaria also imposes a large
economic burden on developing countries. Current efforts to
control this disease are multifaceted and include use of insecticides
and insect barriers, drug therapy, and strengthening healthcare
and research infrastructures [2]. More consistent and widespread
implementation of existing tools would be beneficial, although
technical problems such as selection for chemico-resistance in
vectors and parasites emphasize the need for a new generation of
malaria control tools [3].
One such new approach could be limiting the genetic
propensity of vector mosquitoes to serve as competent hosts for
parasite development, thus decreasing or abolishing their ability to
transmit the causative agent. This approach is in its infancy and
much remains to be done before we can evaluate specific genetic
resistance mechanisms and the feasibility of manipulating them in
nature.
We designed a phenotype-based method to genetically screen
the wild A. gambiae population for genomic regions important in
defense against P. falciparum [4]. Using this approach, we identified
a genetic locus on chromosome 2L that consistently explains
.80% of the variation in infection outcome (i.e., surviving oocyst
numbers) in mosquitoes exposed to an infective bloodmeal, and
thus captures most of the natural genetic variation for P. falciparum
resistance or susceptibility [5]. The genetic interval, currently
,10 Mb, was termed the Plasmodium-Resistance Island (PRI). We
then employed the rodent malaria laboratory model of P. berghei
[6–12] to functionally screen candidate genes in the PRI. This
work identified APL1, a novel leucine-rich repeat (LRR)
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reduced by RNAi gene knockdowns, the number of P. berghei
oocysts was increased up to 20-fold, showing it to be a potent
factor for host defense against P. berghei infection [5].
Here, we reannotate the original APL1 gene as a gene family of
3 related members, APL1A, B, and C. Gene-specific RNAi assays
show that all of the malaria-protective activity we previously
reported for A. gambiae APL1 can now be attributed exclusively to
APL1C. We functionally dissect the position of APL1C in mosquito
immune signaling networks, placing APL1C as a required node in
Rel1-mediated host defense against P. berghei infection. Finally, we
identify haplotypes in the APL1 locus that are genetically
associated with the degree of phenotypic susceptibility to P. berghei
infection.
Results
Reannotation of the ENSEMBL prediction for APL1
Examination of APL1 at the time of our original description [5]
suggested that its annotation as a single gene (EN-
SANGG00000012041 in ENSEMBL version 44 and earlier) was
incorrect. The previous ENSEMBL prediction for APL1 lacked
start and stop codons, predicting a partial protein consisting of
little more than a string of LRR domains. Resequencing of
genomic DNA and archived clones from the original A. gambiae
sequencing project [13], as well as transcript mapping, revealed
that the previous APL1 gene represented the erroneous annotation
of a gene family comprised of at least 3 tandem LRR-containing
genes, here named APL1A, APL1B, and APL1C (Figure 1A). Each
of the 3 genes has a short 59 exon followed by a small intron and a
longer second exon, and each has a block of LRR motifs flanked
by an N-terminal signal peptide and C-terminal coiled coil
domains (Figure 1B). The three individual APL1 genes display
sequence similarity that likely results from gene duplication and
functional diversification (diagonals in Figure S1), and we
therefore class them together as the APL1 family.
There were notable structural differences between the rese-
quencing results and the ENSEMBL genome assembly (discussed
in order below): i) the presence of structurally polymorphic
haplotypes, and ii) a polymorphic and/or active transposable
element. First, all three APL1 family genes display major structural
haplotypes (Figure 1B). The differences between allelic forms are
most striking for APL1A and APL1C. Variants can differ in the
locations of their predicted stop codons, resulting in predicted
proteins of distinct lengths, and also by the presence of multiple
polymorphic insertion-deletion (indel) sites within the protein
coding sequence (CDS). The indels are precisely in-frame with the
surrounding protein. Thus, the indels do not introduce missense
Figure 1. A. Reannotation of the APL1 region. i) Ensembl release version 36, ii) Ensembl release version 41, iii) Ensembl release version 45, iv)
Empirical annotation of APL1A, B and C in this article and Vectorbase manual annotation database, v) Fragments used for RNA interference assays;
common dsRNA fragment knocking down APL1A, B and C (pink), unique dsRNA fragments at the 39 end of each gene used for gene-specific
knockdowns (yellow), vi) 59 and 39 RACE fragments used to delimit transcripts. B. APL1 family protein functional motifs. Predicted peptide
domains are indicated as follows: red, signal peptide; green, coiled-coil domain; light blue vertical bars, leucine rich repeats; blue, regions of intrinsic
disorder, pink, segments of low complexity; and purple, repeat regions. Haplotypic versions of the APL1 proteins as discussed in the text differ in
functional predictions, with PEST strain predictions being most similar to the APL1A
2,B
2, and C
2 haplotypic forms.
doi:10.1371/journal.pone.0003672.g001
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present or absent, respectively, in the predicted finished protein. In
a sample of wild and colony mosquitoes, indel alleles appear
consistently linked to specific surrounding nucleotide variants
(discussed below), thus establishing the indels as reliable markers
for stable haplotypes that encode predicted proteins of distinct
sizes and structure. The haplotypes are designated by the gene
name followed by a superscript number (Figure 1B). The
superscript 2 haplotype for each gene is most similar to the
variant found in the PEST strain used for the A. gambiae genome
sequence.
Another structural difference revealed by resequencing occurs
upstream of the APL1A gene, where we found that a tract of Ns in
the public genome assembly is actually (in PEST strain plasmid
clone 19600445759751) a TA-III-Ag miniature inverted transpos-
able element (MITE, [14]). The ambiguous bases in the
ENSEMBL genome sequence may result from the difficulty in
sequencing the repetitive region, or perhaps from the polymorphic
state of the MITE in the sequence template. The G3 strain lacks
the MITE in this genomic location.
APL1C is required for the control of P. berghei infection
We previously demonstrated that the APL1 family had a
pronounced effect on P. berghei oocyst intensity in an RNAi gene
expression knockdown assay [5]. In that case, the double-stranded
RNA (dsRNA) fragment injected into mosquitoes was fortuitously
common to a portion of all three APL1 family genes (Figure 1A,
track v, homology regions of APL1-common dsRNA indicated by
pink bars; also Figure S1B), because at the time APL1 was
annotated as a single gene. Based on our current reannotation of
APL1, we wondered whether the source of our previously reported
APL1 knockdown phenotype was a single APL1 family member, or
alternatively a combined effect of all 3 members. To test this, we
conducted knockdown experiments using new dsRNA constructs
specific for each of the APL1 family members (locations of dsRNAs
shown in Figure 1A, track v, yellow bars). The results indicate that
among the APL1 family, APL1C alone is responsible for the control
of P. berghei oocyst intensity (Figure 2). Oocyst loads in either
APL1A or APL1B knockdown mosquitoes were statistically
indistinguishable from those of the GFP controls, while APL1C
knockdown mosquitoes carried oocysts loads ,20 times greater
than GFP controls (p,0.05). The effect of the APL1-common
dsRNA fragment that silences the three genes was not different
from the APL1C specific dsRNA, indicating that the effect of
APL1C is both necessary and sufficient to explain APL1 protective
function against infection with P. berghei.
APL1C activity is required for anti-P. berghei protection
mediated by the Toll/Rel1 pathway
The Toll signaling pathway controls cellular and humoral
innate immune signaling, including activation of anti-fungal and
anti-Gram positive bacteria defense in Drosophila [15,16] The
genes for the core components of the pathway are also found in the
A. gambiae and Aedes aegypti genomes [17,18]. Mosquito Rel1,
ortholog of Drosophila Dorsal and functional analog of Drosophila
Dif, is an ultimate transcription factor of the Toll pathway
[11,19,20]. Under naı ¨ve conditions, Rel1 is retained in the
cytoplasm due to binding of the inhibitor, Cactus. Activation of
the Toll receptor by its ligand spatzle in response to pathogens
results in the disassociation of Cactus from Rel1 [21]. Released
Rel1 translocates to the nucleus where it transactivates target
genes. Recently, Frolet et al. [11] have shown that Rel1 regulates
the transcription of TEP1 and LRIM1, two anti-Plasmodium genes
in A. gambiae, and that depletion of the Rel1 inhibitor, Cactus, by
RNAi strongly promoted mosquito host defense against P. berghei.
In the same study, it was claimed that APL1 was not
transcriptionally regulated by Rel1. However, the PCR assay
used for the APL1 expression in their study was actually specific for
the AGAP007037 gene (upstream of APL1A), which was
incorrectly annotated as an exon of APL1.
A specific assay for the expression of APL1C, the only anti-P.
berghei gene among the 3 APL1 genes, reveals that APL1C is in fact
regulated by Rel1, as determined by its expression in Rel1 and
Cactus knockdown mosquitoes (Figure 3). APL1C transcription
was reduced in dsRel1 treated mosquitoes, and increased in
dsCactus treated mosquitoes (Figure 3A). Furthermore, APL1C
protein abundance was elevated following P. berghei infection, and
this elevation was enhanced by dsCactus (Figure 3B). Boosting Rel1
signaling by depletion of Cactus enables mosquitoes to eliminate
almost all invaded malaria parasites within 48 h post-infection
[11]. If APL1C is a host-protective gene regulated by Rel1/Cactus
signaling, then the anti-P. berghei effect of dsCactus should be
reduced in the absence of APL1C expression. To test this
hypothesis, we examined the effect of a dsCactus/dsAPL1C double
Figure 2. Among the APL1 family, only APL1C specifically
protects against P. berghei infection. The three APL1 family genes
were individually assayed to determine their relative contributions to
host defense against P. berghei infection. Horizontal axis indicates the
gene target of RNAi knockdown, where APL1A, B and C are gene-
specific knockdowns, GFP is an irrelevant control dsRNA, and APL1 is a
shared dsRNA that simultaneously knocks down all 3 APL1 family genes.
Vertical axis indicates the number of midgut oocysts 7–8 d following
IBM, with sample size (n), mean (mean), and median (med). Infection
levels in APL1A and APL1B silenced mosquitoes were not different from
GFP controls. However, treatment with either dsAPL1C or dsAPL1
(targeting all 3 genes) permitted significantly greater oocyst develop-
ment than the other treatments (asterisk, p,0.05 by Dunn’s Multiple
Comparison after Kruskal Wallis one way ANOVA on ranks). Infections of
APL1C and APL1 silenced mosquitoes were not different from each
other, indicating that the function of APL1C alone is sufficient to explain
all of the increased permissiveness caused by complete APL1 family
knockdown. The result for each knockdown target represents pooled
data from at least 2 independent replicate experiments. One of the
common APL1 knockdowns was done alongside an APL1C kd, and when
assayed in the same replicate, there was no significant difference
between APL1C kd and common APL1 kd (p=0.481). The inset gel
photo shows representative examples of gene knockdown efficiency for
the 3 members of the APL1 gene family. Labels above gel images
indicate the dsRNA that was used for the knockdown. Labels to the left
of images indicate the transcript detected by RT-PCR on RNA purified
from the treated mosquitoes. rps7 was used as a control for cDNA input
in PCR.
doi:10.1371/journal.pone.0003672.g002
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control mosquitoes treated only with dsCactus eliminated all
invaded parasites by either lysis or melanization responses. Most
dsCactus mosquitoes (24/36) harbored no parasites on day 7 post-
IBM, while the remaining third of the mosquitoes (12/36)
displayed melanized parasites (range 1–19 melanized parasites/
mosquito) but no normal oocysts. Interestingly, this elevated
parasite resistance of dsCactus treated mosquitoes was completely
reversed when APL1C was silenced simultaneously with Cactus,
because the oocyst load in mosquitoes treated with dsCactus/
dsAPL1C was equivalent to that in dsAPL1C/dsGFP treated
mosquitoes (Figure 3C). These results indicate that APL1C is a
required mediator of the anti-P. berghei effect controlled by Rel1
signaling, because constitutive activation of Rel1 signaling by
Figure 3. A. APL1C mRNA is regulated by the Rel1/Cactus immune signaling pathway. Semi-quantitative RT-PCR was used to measure the
effect of Rel1 and Cactus knockdown on APL1C transcript abundance. Labels above gel indicate the dsRNA that was used for the knockdown, labels to
the left indicate the transcript whose abundance was measured. APL1C level was decreased by Rel1 silencing, and increased by Cactus silencing,
consistent with a model whereby APL1C RNA is regulated positively by Rel1 and negatively by Cactus. Specificity is shown by dsRel1 and dsCactus
silencing of cognate RNA levels. B. APL1C protein abundance is regulated by P. berghei infection and Cactus. Western blot analysis of
APL1C protein abundance 24 h after P. berghei infection in naı ¨ve, dsCactus knockdown, and dsGFP control mosquitoes. Total protein abundance of
ERK detected by anti-ERK antibodies was used as a protein loading control. C. APL1C is required for Rel1-mediated host-defense against P.
berghei. The functional effect of Cactus and APL1C activity on the outcome of P. berghei infection was tested using gene knockdowns. The RNAi
knockdown target is shown on the horizontal axis. GFP was used as a control dsRNA. The vertical axis shows the number of midgut oocysts 7–8 d
following a P. berghei IBM. Sample sizes (n), means (mean), and medians (med) are given for knockdowns, which were each pooled data from 2
independent experiments. The oocyst loads differed significantly (p,0.001) among samples by Kruskal Wallis one way ANOVA on Ranks. Pairwise
comparisons using Dunn’s method of multiple comparisons are given in the inset box. dsCactus-treated mosquitoes were completely protected from
infection, with no successful oocyst development. In distinction, the double knockdown of APL1C simultaneously with Cactus produced mosquitoes
with ,25-fold more oocysts than the dsGFP-treated controls, a result that was no different than the dsAPL1C-treated mosquitoes. Thus, in the
absence of APL1C, Rel1 activation has no effect on parasite development, indicating the requirement of the presence of APL1C for Rel1-mediated
host defense against P. berghei. Note that dsGFP was included in the APL1C knockdown so that total amount of input dsRNA per mosquito was the
same as in the Cactus-APL1C double knockdown, eliminating dsRNA concentration as a variable.
doi:10.1371/journal.pone.0003672.g003
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mosquitoes, had no effect in the absence of APL1C. Treatment
of mosquitoes with dsRNA for two other mosquito immune
factors, TEP1 and LRIM1, only partially reversed the dsCactus
phenotype in double knockdowns, allowing development of some
normal P. berghei parasites [11]. However, because Cactus
depletion confers no host-protective phenotype without the
presence of APL1C, it appears that the effect of APL1C is
functionally dominant in this anti-P. berghei pathway. We
hypothesize that APL1C may be a functionally upstream signaling
node responsible for the coordinated Rel1-dependent control of
multiple host protective factors.
Haplotypes at the APL1 locus are genetically associated
with protection from P. berghei infection
Resequencing and reannotation of the APL1 locus identified
major structural haplotypes that include alleles of APL1A, APL1B,
and APL1C (Figure 1B). We hypothesized that the genetic and
predicted protein variation in this locus could control differences
for host defense against P. berghei. If true, one could test for the
phenotypic effect of different haplotypes by detecting association
of haplotype-specific markers with phenotypic outcome after P.
berghei infection.
To design a genetic assay for haplotype, we resequenced part of
the APL1A and APL1C genes in a sample of colony and wild
mosquitoes. Patterns of specific SNPs distinguish the APL1
haplotypes and are stable among mosquitoes of distinct geographic
origins (Figure 4A). Thus, we designed a simple PCR fragment
length assay to detect the genotype of indels in APL1A (Figure 4B,
C). Typing of multiple mosquitoes using the PCR assay indicated
that the indels are linked to and diagnostic for the APL1 haplotypes
(not shown). In summary, the APL1A
1 haplotype bears the deleted
variant of an indel located in exon 2, while APL1A
2 bears the
inserted variant for this indel. APL1A
2 bears the deleted variant of
an indel located 59 to the predicted translation start site, while
APL1A
1 bears the inserted variant of this indel (Figure 4B). The
exon 2 indel is an in-frame CDS deletion, which consequently
alters the length of the predicted protein product but does not
introduce missense/nonsense mutations (not shown).
We challenged the G3 strain A. gambiae with a P. berghei-infected
bloodmeal, and used the indel genotyping assay to query for an
association between APL1 genotype and infection outcome
(Figure 4D). Mosquitoes that were homozygous for APL1A
2 had
significantly lower oocyst loads (average=5.362.5) than APL1A
1/
APL1A
2 heterozygotes (average=31.766; Mann Whitney Rank
Sum Test, p,0.001). Furthermore, the prevalence of infection in
homozygous APL1A
2 mosquitoes was lower (37.5%; 9/24) than
that in APL1A
1/APL1A
2 heterozygotes (84.5%; 41/48; Fisher’s
Exact Test, p,0.001).
Thus, the haplotype-tagging indels are linked to genetic variation
that controls significant difference in numbers of surviving P. berghei
oocysts. We emphasize that the indels serve as genetic markers to
detect the phenotypic effect of linked variant sequences, and linkage
does not imply that the marker itself underlies the observed
phenotypic variation. Like any other genetic marker in common
use, for example almost all microsatellites and SNPs in any given
genome, the allelic variation of the marker itself is presumed to be
neutral for the trait under examination. Thus, further genetic
studies will be necessary to resolve the underlying cause at the APL1
locus of this phenotypic difference.
Based on the observation that APL1A
2 homozygotes are less
susceptible and APL1A
1/APL1A
2 heterozygotesaremore susceptible
to P. berghei infection, one might predict that APL1A
1 homozygotes
would in turn be exceedingly susceptible for infection. However, the
G3 colony of A. gambiae displays a low frequency of APL1A
1
homozygotes (8%) and thus the sample sizes of these individuals
(n=2) obtained after a moderate number of infections was too small
to include in the statistical analyses. The APL1A
1 homozygotes must
certainly be generated each generation by the mating of
heterozygotes, but due to their low frequency their fate and
potential infection phenotype remains an open question. Typing
mosquito developmental stages using the haplotype diagnostic
showed the same haplotype frequencies in eggs and larvae as in
adults (data not shown), suggesting that loss of the APL1A
1
homozygotes is not developmental but rather prezygotic.
Discussion
We demonstrate by RNAi gene silencing experiments that
APL1C activity is necessary to provide a high level of host-
protective activity against P. berghei infection. By genetic associa-
tion, we show that variant haplotypes at the APL1 locus confer
distinct levels of parasite susceptibility or resistance. Further
functional and cell biological studies will be necessary to
understand the role of APL1C in host defense against P. berghei
and other parasite species, most importantly the human malaria
parasite, P. falciparum. Further genetic studies will be required to
dissect the functional basis of the distinct infection phenotypes
linked to the APL1 haplotypes.
Methods
Sequence Generation and Comparison
For PCR amplification and subsequent sequencing of the APL1
region, DNA was isolated from a single female G3 strain mosquito
using Qiagen DNeasy (Qiagen, CA, USA). Diploid sequence was
obtained via standard Sanger sequencing at the BioMedical
Genomics Center at the University of Minnesota and assembled
using Seqman (DnaStar, WI, USA). Due to the diploid nature of
the starting DNA, no phase information is known and ambiguous
base calls are given for reliably called heterozygous positions.
Three PEST clones (Clones 19600445682690, 19600445759751,
19600445654898) spanning this APL1 region were obtained from
the Malaria Research and Reference Reagent Resource Center,
MR4 (www.mr4.org). Clones overlapping the APL1 gene predic-
tions were sequenced and assembled as described above (map in
Figure S1C). The three assembled sequences (G3, ENSEMBL, and
PEST clones) were aligned and a comparison plot drawn using
ACT [22]. The score cut-off was set to 100, the % ID cutoff to 50%
and the minimum size of matches was set to 100 bp or greater.
Manual Annotation of the APL1 Gene Family
Both molecular biology and in silico approaches were used to
manually annotate the three member genes of the APL1 family. All
wet biology work was done on cDNA synthesized from total RNA
isolated from a pool of 30 G3 strain femalemosquitoes. Gene model
predictions from a whole genome in silico prediction of the A. gambiae
genome [23] were considered alongside data from 59 and 39 RACE
reactions (First Choice RLM-RACE Kit, Ambion, Ca, USA) run
with gene specific primers for APL1A and APL1C including
apl1A_59_end_R GATGGCTGTCCTCCGTTGGTACAGGC,
apl1C_59_end_R CCGTAATTTGGCTGACTTCTGTAGATT,
apl1A_39_end_F CAGCAGCAGCTCCTAGCAAGACTGCA,
and apl1C_39_end_F GGCAAGCGTTTAAGTTGCGC-
GAAACGCA and 59 forward and 39 reverse adaptor primers.
The APL1B transcript was determined by designing primers to
include all possible upstream start and downstream stop codons and
screening for PCR amplification. Once the extent of transcripts was
Mosquito LRR Proteins
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wereamplifiedbyPCRand Sangersequencedresultingincomplete
sequence of the coding regions and the ability to predict the
underlying polypeptide. The resulting new gene models were
submitted to Vectorbase (www.vectorbase.org) as manual annota-
tion entries (data deposition APL1, manual). Three independently
transcribed genes with start and stop codons are now included
beginning with ENSEMBL release version 45: AGAP007036,
APL1A; AGAP007035, APL1B; and AGAP007033, APL1C.
Protein Structural Architecture of the APL1 Family
Predicted peptide sequences of the haplotypic forms of the
APL1 family were generated from the resequencing data described
above and were aligned using ClustalX [24]. SMART [25] was
used to obtain predictions for the protein domains using HMMER
searches and also searching for outlier homologues, Pfam domains,
signal peptides, internal repeats, and regions of intrinsic protein
disorder. The protein domains depicted in Figure 1B are adapted
from SMART output that only displays domains more significant
than established cutoffs. When two or more features occupy the
same region, the following order of preference was used
SMART.PFAM.PROSPERO repeats.Signal peptide.Trans-
membrane.Coiled coil.Unstructured regions.Low complexity.
APL1C Antibodies
An APL1C specific gene fragment was PCR amplified with the
following primers APL1C_F 59 CAAGCGTTTAAGTTGCGC-
GAAACGCAG and APL1C_R 59 CTACTTTGTAACGC-
GACGCGTATCTGG. The fragment was expressed from the
pet-46 Ek/LIC vector (Novagen, CA, USA), and was used for
production of rabbit antisera. IgG was purified from serum using
Protein A IgG Purification Kit from Pierce Biotechnology
(Rockford, IL, USA), and made to a concentration of 1 mg/ml.
Mosquito proteins were separated by 4–12% SDS-PAGE gels of
the NuPAGE Novex Bis-Tris system (Invitrogen, Carlsbad,
California, USA), transferred to the Nitrocellulose membrane.
Figure 4. A. APL1 alleles are comprised of blocks of linked SNPs. Nucleotide alignment shows APL1A and APL1C genetic variation in a sample
of A. gambiae wild and colony mosquitoes. Haplotypes are shared over the resequenced region between individual mosquitoes, indicating that the
variants are stable haplotypes that exist in A. gambiae at appreciable frequency. B. Genotyping assay for segregating indels in the APL1 locus.
A PCR assay was designed to test the state of 2 indels in APL1A that are markers for allelic haplotypes at the APL1 locus. Arrows show forward and
reverse primers used in the diagnostic assay, dashed lines indicate indels (located within exon 2 of APL1A
1, and above the translation start in APL1A
2),
asterisk indicates the start codon of APL1A. C. Indel genotyping assay. A representative gel of PCR products from the indel diagnostic assay, lane
1, Lambda HindIII/PhiX HaeIII marker, lane 2, APL1A
2 homozygote (854 bp), lane 3, a heterozygote with codominant bands, lane 4, APL1A
1
homozygote (663 bp). D. APL1 locus haplotypes control distinct levels of protection from P. berghei infection. Homozygous APL1A
2
mosquitoes were significantly less permissive for parasite development than APL1A
1/APL1A
2 heterozygotes (asterisk, p,0.001, Mann Whitney Rank
Sum Test; sample size (n), mean (mean), and median (med) given for each haplotype). Homozygous APL1A
1 individuals are present at low frequency
in the sampled colony and thus were not included in the analysis (see Results for further details on APL1A
1 haplotype frequency).
doi:10.1371/journal.pone.0003672.g004
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dilution) was done with the Protein Detector LumiGLO Western
Blotting kit (KPL, Gaithersburg, Maryland, USA). The protein
loads on the blot were checked by staining with anti-ERK2 total
antibody (item K-23 #sc-153, Santa Cruz Biotechnology, Santa
Cruz, CA, USA) at a concentration suggested by the supplier.
RNA Interference Assays
Gene specific fragments of APL1 A, B and C, Rel, Cactus and GFP
were produced by PCR using oligos tagged at 59end with T7
promoter sequence. The primers used were: GFP_F 59 AGTGGA-
GAGGGTGAAGGTGA, GFP_R 59 CACGTGTCTTG-
TAGTTCCCG, APL1A_F 59 CTACCACCTGCCGAAAGATG,
APL1A_R 59 TCTGGTCTTGTATAGTACAATGG, APL1B_F
59 TGAGAACAAATAAGTTCAAAGTCC, APL1B_R 59
ACTCGCAAAGCTCAGCAAACAC, APL1C_F 59 CCAAGAA-
GAACCGCAATCC and APL1C_R 59 TCACAGTGATTT-
CAGGGTGTGC, REL1_F 59GGCCCTAGTCAGCCG-
CAGCCGandREL1_R59GGGGGGTTGGAATGGATGCTT;
CACTUS_F 59 GGTGGTGCGTCGATTGCTGG and CAC-
TUS_R 59 GGCTTTCGTTCAAGTTCTGTGC (all primers
contained a T7 promoter sequence, 59 TAATACGACTCACTA-
TAGG for use in synthesizing dsRNA; the GFP fragment was used
as a dsRNA control). The PCR products were used as templates for
dsRNA synthesis using the MEGAscript T7 Kit (Ambion, TX,
USA). Four d after the dsRNA treatment, knockdown of the target
gene was verified. dsRNA treated mosquitoes were fed on mice
infected with PbGFPCON (8–12% parasitaemia with mature
gametocytes), a transformed strain of P. berghei constitutively
expressing GFP [26] at 8–12% parasitaemia with mature
gametocytes. Seven to 8 d following infective blood meal, midgut
oocysts were counted using a florescence microscope. To compare
oocyst numbers across treatments non-parametric statistical tests
were used, including the Mann Whitney Rank Sum Test and the
Kruskal Wallis ANOVA on ranks. For each RNAi experiment at
least 30 mosquitoes survived and were counted for oocyst load. Two
to 4 independent replicate infections were performed and data was
pooled prior to statistical analysis.
Indel Genotype-Phenotype Association Study
During the sequencing of the APL1 gene family in a single G3
colonymosquito2 segregating variants (haplotypes)werediscovered
(see Results). Based on available DNA sequence from homozygotes
ofthe twosegregatinghaplotypes,aPCRbaseddiagnosticassaywas
designed to detect 2 segregating indels within APL1A. The first indel
(46 bp in length) was located 109 bp upstream of the predicted
translation start site and the second indel (237 bp in length) was
located in the second exon. Amplification across this variable region
resultsindifferencesinPCRproductlengthof191 bpintheAPL1A
gene, and was used to genotype mosquitoes for allelic haplotypes of
the APL1 locus. Homozygous APL1A
1 individuals displayed a single
PCR of 663 bp, homozygous APL1A
2 individuals displayed a single
PCR band of 854 bp, and heterozygotes displayed both bands. The
primers used in the haplotype diagnostic assay were 59 GCT GGA
TCC CAA CTA GTG CTG TT and 59 AGT AAA GCA GCG
GGC AGT TTG C. PCR conditions were 94uC for 1 minute,
followed by 30 cycles of 94uC for 30 sec, 58uC for 30 sec, and 72uC
for 45 sec and a final extension of 72uC for 7 minutes. To query for
an association between haplotype and infection phenotype, G3
mosquitoes were fed on mice infected with the PbGFPCON strain
of P. berghei (18) as described above. Seven to eight days post blood
feeding midguts were dissected, oocysts counted, mosquito genomic
DNA extracted from carcasses, and APL1A haplotype was
determined by the diagnostic assay for each individual. Three
replicate infections were performed and data was analyzed with a
non-parametric Wilcoxon Mann Whitney test.
Supporting Information
Figure S1 A. Reannotation of the APL1 region (reproduced
from main text for clarity with Figure S1). i) Ensembl release
version 36, ii) Ensembl release version 41, iii) Ensembl release
version 45, iv) Empirical annotation of APL1A, B and C in this
article and Vectorbase manual annotation database, v) Fragments
used for RNA interference assays; common dsRNA fragment
knocking down APL1A, B and C (pink), unique dsRNA fragments
at the 39 end of each gene used for gene-specific knockdowns
(yellow), vi) 59 and 39 RACE fragments used to delimit transcripts.
B. Genomic similarity. ACT Sequence Comparison plot of i) a
single G3 female, ii) the genomic sequence of A. gambiae from
ENSEMBL and iii) sequence from three PEST clones spanning
the region. Score cut-off was set at a minimum of 100, per cent ID
cut-off was set to a minimum 50% and minimum size of matches
was set to 100 bp or greater. Greater sequence identity is indicated
by darker shade of red. Extensive sequence similarity is evident
across the APL1 locus region, with many regions .95% and most
.90%. The assembled PEST strain sequence at ENSEMBL
shows greater similarity to independent PEST clones than it does
to G3. The LRR regions of the APL1 genes show greatest
intergene similarity (diagonals). The largest region of sequence
dissimilarity occurs upstream of the 59 end of the APL1A gene.
Here the ENSEMBL sequence is a string of Ns (see white box in
track ii), the PEST clone has a miniature inverted transposable
element (MITE) of the TA-III-Ag family based on terminal
inverted repeat sequence and the G3 sequence has no MITE. C.
Overlap of the PEST strain clones with the APL1 gene family. a)
The APL1 gene family as presented throughout this paper, APL1A
(green), APL1B (red), and ALP1C (blue) (b) The three PEST
clones obtained from MR4.
Found at: doi:10.1371/journal.pone.0003672.s001 (1.62 MB TIF)
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